Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to treat solid tumor cancers and chemotherapy-induced peripheral neuropathy (CIPN) ...

SAN FRANCISCO, Dec. 16, 2025 /PRNewswire/ -- Hospitals and health systems overwhelmingly prefer artificial intelligence (AI) models that combine technology with clinical expertise, according to new ...

SAN FRANCISCO, Dec. 9, 2025 /PRNewswire/ -- Carta Healthcare ®, a leading provider of AI-powered clinical data abstraction solutions, announced today that it has earned first-place Gold recognition ...

First, institutions must ensure that synthetic datasets are continuously recalibrated against fresh, real-world evidence. The ...

Results show strong preference for AI paired with clinician oversight; concerns about "black box" risks persist SAN FRANCISCO, Dec. 16, 2025 /PRNewswire/ -- Hospitals and health systems overwhelmingly ...

The collaboration builds on successful pilot projects at the University of Texas Medical Branch (UTMB) and the University of Texas Health Science Center at San Antonio (UTHSCSA), now part of UT San ...

As part of conversations between AI healthcare leaders on the podcast AI Amplified this year, a clear picture emerged of where artificial intelligence is genuinely transforming healthcare — and where ...

A Potential New Standard for First-Line HER2+ Advanced GEA* Combination therapy showed compelling survival and disease control compared to current standard, regardless of PD-L1 status* High GEA burden ...

No treatment-related adverse toxicity was observed across completed GLP studies, with consistent systemic exposure following ...